Asset Publisher

Ministry of Health Reduces the Prices of 10 Therapeutic Groups

Ministry of Health Reduces the Prices of 10 Therapeutic Groups

Ministry of Health Reduces the Prices of 10 Therapeutic Groups

30/6/2015

As a second phase of revision of drugs pricing project that was released on last October, the Sultanate witnesses today the 1st of July prices reduction of 1180 new drugs in private pharmacies. The project in its first phase covers 1400 drugs from five therapeutic groups, which are cardiovascular drugs, endocrine drugs, gastrointestinal drugs, skin drugs, and musculoskeletal and joint drugs.

The Ministry of Health represented by The Directorate General of Pharmaceutical Affairs & Drug Control (DGPA&DC)  has finished the pricing revision of approximately another 1180 drugs of the remaining therapeutic groups namely Antibiotics drugs, respiratory system drugs, psychotropic diseases drugs, ophthalmic drugs, ENT diseases drugs, Cancerous  diseases drugs, Hematology and some of blood products and vaccines.

The reduced prices has been circulated to the companies’ agents in the Sultanates on November 2015. In addition, the list of the drugs was uploaded in the Ministry’s website and a period of five months was granted to the drugs’ manufactured companies to state any remarks concerning the approved prices and amend those prices in all of the Sultanates pharmacies according to the determined date. Every agent shall take the responsibility of amending the prices of the drugs in all pharmacies.

Ministry of Health represented by DGPA&DC will follow the implementation of the reduced prices in all of the Sultanate pharmacies, starting from today (Wednesday) the 1st of July. The inspection will be conducted by the concerned departments of DGPA&DC and in collaboration with the Directorates General of for Health Services in all of the Sultanates Governorates to ensure the undertaking of the new prices.

It is worth to mention that the Directorate approved some new mechanisms, which allow revision of the drugs prices once the Patent period terminates or when change in the drug prices occurs in the source country or internationally for any possible reason. Drug revision also take place when re-registration file submitted for approval every five years. All these repricing mechanism lead to periodical price review and reduction.   

The Ministry notifies that the prices of drugs must be set by the official agent of each drug on all registered drugs. The agent should change the prices in all pharmacies in case that the Ministry changed them.  The reduced prices are available at the MOH’s website and they are continuously updated and when is demanded.

Therefore, the Ministry calls every one to view those list via its website ( www.moh.gov.om). Any observation of any alteration in prices or for any other remarks, contact the Ministry’s Contact Centre on: 24441999. 

 

 



Comments